|
⚲
|
| Keyboard |
| Gollob Jared
✚
|
|
|---|---|
| CIK # | 0001821198 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001821198] | |
| 4 | [0001821198] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kymera Therapeutics Inc | |
| Gollob Jared |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-03-04 | Sell | 1,437 | $85.78 | 123,266 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-03-04 | Sell | 447 | $86.62 | 38,719 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-03-04 | Sell | 2,519 | $85.04 | 214,216 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-03-04 | Sell | 492 | $84.00 | 41,328 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-03-02 | Sell | 1,510 | $87.75 | 132,502 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-03-02 | Sell | 1,055 | $88.50 | 93,368 |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 35,300 | $0.00 | |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-03-02 | Sell | 3,048 | $89.66 | 273,284 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2026-03-02 | Grant | 17,650 | $0.00 | |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-12-08 | Sell | 8,562 | $90.12 | 771,607 |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2025-12-08 | Option exercise | 49,307 | $0.00 | |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-12-08 | Option exercise | 49,307 | $5.33 | 262,806 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-12-08 | Sell | 1,400 | $92.19 | 129,066 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-12-08 | Sell | 13,759 | $87.37 | 1,202,124 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-12-08 | Sell | 18,357 | $88.02 | 1,615,783 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-12-08 | Sell | 3,929 | $89.43 | 351,370 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-12-08 | Sell | 3,300 | $91.46 | 301,818 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-10-15 | Option exercise | 22,210 | $2.08 | 46,197 |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2025-10-15 | Option exercise | 28,999 | $0.00 | |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2025-10-15 | Option exercise | 22,210 | $0.00 | |
| showing 20 of 90 most recent transactions | |||||